African Medicines Agency enhances regulatory cooperation with European Medicines Agency

Date: 2026-06-29
news-banner

By:  Kanto Kai Okanta

The African Medicines Agency (AMA) has reinforced its partnership with the European Medicines Agency (EMA) following a high-level visit by an AMA delegation to the EMA headquarters in Amsterdam.

The visit, which took place from 22 to 26 June 2026, formed part of ongoing efforts by the two continental regulatory agencies to deepen collaboration through technical cooperation, knowledge exchange, and mutual learning.

During the engagement, officials from both organizations discussed shared priorities aimed at strengthening regulatory systems and supporting the development of efficient, modern medicines regulation across Africa and Europe.

Key discussions focused on digital transformation initiatives, support for pharmaceutical innovators and local manufacturers, and the adoption of best practices to improve regulatory efficiency and effectiveness.

As part of the visit, AMA Director-General Dr. Delese Mimi Darko delivered an interactive presentation to EMA staff outlining the progress made in operationalizing the African Medicines Agency and highlighting opportunities to further expand collaboration between the two organizations.

The discussions also explored ways to leverage the expertise of both agencies to strengthen regulatory capacity, promote innovation, and enhance access to quality-assured medical products.

AMA noted that its partnership with the European Medicines Agency remains an important component of its efforts to build robust regulatory systems capable of safeguarding public health while supporting the growth of Africa's pharmaceutical sector.

The agency said continued cooperation with the EMA will contribute to advancing regulatory excellence and improving access to safe, effective, and quality-assured medicines and medical products across both regions.

The visit reflects the shared commitment of the African Medicines Agency and the European Medicines Agency to strengthening international regulatory cooperation and promoting harmonized approaches that support public health, innovation, and sustainable healthcare systems.

 

Leave Your Comments